Cargando…

Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique

OBJECTIVES: To compare hematologic and serological parameters among patients with Sjogren’s syndrome (SS), dry eye syndrome (DES) and controls, and validate a novel multiplex-serology method for identifying auto-antibodies in these populations. METHODS: In a clinic-based case-control study a total o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Eli, Hadas, Solomon, Abraham, Aframian, Doron J., Ben-Chetrit, Eldad, Mevorach, Dror, Kleinstern, Geffen, Waterboer, Tim, Willhauck-Fleckenstein, Martina, Pawlita, Michael, Paltiel, Ora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774976/
https://www.ncbi.nlm.nih.gov/pubmed/33382786
http://dx.doi.org/10.1371/journal.pone.0244712
_version_ 1783630375303512064
author Ben-Eli, Hadas
Solomon, Abraham
Aframian, Doron J.
Ben-Chetrit, Eldad
Mevorach, Dror
Kleinstern, Geffen
Waterboer, Tim
Willhauck-Fleckenstein, Martina
Pawlita, Michael
Paltiel, Ora
author_facet Ben-Eli, Hadas
Solomon, Abraham
Aframian, Doron J.
Ben-Chetrit, Eldad
Mevorach, Dror
Kleinstern, Geffen
Waterboer, Tim
Willhauck-Fleckenstein, Martina
Pawlita, Michael
Paltiel, Ora
author_sort Ben-Eli, Hadas
collection PubMed
description OBJECTIVES: To compare hematologic and serological parameters among patients with Sjogren’s syndrome (SS), dry eye syndrome (DES) and controls, and validate a novel multiplex-serology method for identifying auto-antibodies in these populations. METHODS: In a clinic-based case-control study a total of 422 participants were recruited, including 91 with SS, 120 DES, and 211 controls (age and sex frequency-matched). We measured blood counts, anti-nuclear-antibodies (ANA), anti-SSA/SSB, anti-ribonucleoprotein (RNP), anti-double-stranded-DNA (DS-DNA), and rheumatoid factor (RF) using the “Immunodot” qualitative-ELISA assay. Immunoglobulins, C3 and C4 were measured by immune-fluorescence. Autoantibodies were also quantified with a newly-developed method using glutathione-S-transferase fusion proteins of SSA/Ro 52 and 60kD and SSB/La (multiplex-serology), measuring median fluorescence intensity (MFI). RESULTS: Among DES patients, only 2% (95%CI: 0.36–6.3) had positive immune serology. SS patients had lower lymphocyte, hemoglobin and C3 levels but higher prevalence of RF, ANA, anti-SSA/B and higher IgG and MFI levels, compared to DES and controls (P<0.001). Presence of anti-SSA/Ro-52kD was associated with SS [odds ratio (OR) = 2.05, 95% confidence interval (CI): 1.46–2.88]. Anti-SSB/La was inversely associated with DES (OR = 0.81, 95%CI: 0.65–1.00) compared to controls. Positivity to RF (adjusted for age, gender and ethnicity OR = 5.03, 95%CI: 1.78–14.21), ANA (OR = 14.75, 95%CI: 4.09–53.17), or combination of anti-SSA/B (OR = 20.97, 95%CI: 4.60–95.54) were more likely in SS compared to DES. The novel multiplex-serology method correctly identified anti-SSA/B autoantibodies by ELISA among SS, DES patients and controls (sensitivity = 1.0, negative-predictive-value = 1.0). CONCLUSIONS: Serologic parameters distinguish SS from DES patients and controls. A newly-developed multiplex-serology technique may be useful to detect autoantibodies in large epidemiologic studies.
format Online
Article
Text
id pubmed-7774976
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-77749762021-01-11 Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique Ben-Eli, Hadas Solomon, Abraham Aframian, Doron J. Ben-Chetrit, Eldad Mevorach, Dror Kleinstern, Geffen Waterboer, Tim Willhauck-Fleckenstein, Martina Pawlita, Michael Paltiel, Ora PLoS One Research Article OBJECTIVES: To compare hematologic and serological parameters among patients with Sjogren’s syndrome (SS), dry eye syndrome (DES) and controls, and validate a novel multiplex-serology method for identifying auto-antibodies in these populations. METHODS: In a clinic-based case-control study a total of 422 participants were recruited, including 91 with SS, 120 DES, and 211 controls (age and sex frequency-matched). We measured blood counts, anti-nuclear-antibodies (ANA), anti-SSA/SSB, anti-ribonucleoprotein (RNP), anti-double-stranded-DNA (DS-DNA), and rheumatoid factor (RF) using the “Immunodot” qualitative-ELISA assay. Immunoglobulins, C3 and C4 were measured by immune-fluorescence. Autoantibodies were also quantified with a newly-developed method using glutathione-S-transferase fusion proteins of SSA/Ro 52 and 60kD and SSB/La (multiplex-serology), measuring median fluorescence intensity (MFI). RESULTS: Among DES patients, only 2% (95%CI: 0.36–6.3) had positive immune serology. SS patients had lower lymphocyte, hemoglobin and C3 levels but higher prevalence of RF, ANA, anti-SSA/B and higher IgG and MFI levels, compared to DES and controls (P<0.001). Presence of anti-SSA/Ro-52kD was associated with SS [odds ratio (OR) = 2.05, 95% confidence interval (CI): 1.46–2.88]. Anti-SSB/La was inversely associated with DES (OR = 0.81, 95%CI: 0.65–1.00) compared to controls. Positivity to RF (adjusted for age, gender and ethnicity OR = 5.03, 95%CI: 1.78–14.21), ANA (OR = 14.75, 95%CI: 4.09–53.17), or combination of anti-SSA/B (OR = 20.97, 95%CI: 4.60–95.54) were more likely in SS compared to DES. The novel multiplex-serology method correctly identified anti-SSA/B autoantibodies by ELISA among SS, DES patients and controls (sensitivity = 1.0, negative-predictive-value = 1.0). CONCLUSIONS: Serologic parameters distinguish SS from DES patients and controls. A newly-developed multiplex-serology technique may be useful to detect autoantibodies in large epidemiologic studies. Public Library of Science 2020-12-31 /pmc/articles/PMC7774976/ /pubmed/33382786 http://dx.doi.org/10.1371/journal.pone.0244712 Text en © 2020 Ben-Eli et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ben-Eli, Hadas
Solomon, Abraham
Aframian, Doron J.
Ben-Chetrit, Eldad
Mevorach, Dror
Kleinstern, Geffen
Waterboer, Tim
Willhauck-Fleckenstein, Martina
Pawlita, Michael
Paltiel, Ora
Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique
title Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique
title_full Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique
title_fullStr Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique
title_full_unstemmed Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique
title_short Serological and hematological characteristics of Sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique
title_sort serological and hematological characteristics of sjogren’s syndrome and dry eye syndrome patients using a novel immune serology technique
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774976/
https://www.ncbi.nlm.nih.gov/pubmed/33382786
http://dx.doi.org/10.1371/journal.pone.0244712
work_keys_str_mv AT benelihadas serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT solomonabraham serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT aframiandoronj serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT benchetriteldad serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT mevorachdror serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT kleinsterngeffen serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT waterboertim serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT willhauckfleckensteinmartina serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT pawlitamichael serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique
AT paltielora serologicalandhematologicalcharacteristicsofsjogrenssyndromeanddryeyesyndromepatientsusinganovelimmuneserologytechnique